Our top pick for
Building a portfolio
CHF Solutions, Inc is a medical devices business based in the US. CHF Solutions shares (CHFS) are listed on the NASDAQ and all prices are listed in US Dollars. CHF Solutions employs 66 staff and has a trailing 12-month revenue of around USD$6.8 million.
|Latest market close||USD$7.09|
|52-week range||USD$0.28 - USD$38.7|
|50-day moving average||USD$7.0603|
|200-day moving average||USD$11.9212|
|Wall St. target price||USD$15|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-21.58|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-14)||-14.06%|
|1 month (2020-12-22)||-5.21%|
|3 months (2020-10-21)||4.42%|
|6 months (2020-07-21)||977.51%|
|1 year (2020-01-21)||550.52%|
|2 years (2019-01-18)||-22.77%|
|3 years (2018-01-19)||82.26%|
|5 years (2016-01-21)||521.93%|
Valuing CHF Solutions stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CHF Solutions's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
CHF Solutions's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1x. In other words, CHF Solutions shares trade at around 1x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
|Revenue TTM||USD$6.8 million|
|Gross profit TTM||USD$2.9 million|
|Return on assets TTM||-68.64%|
|Return on equity TTM||-139.45%|
|Market capitalisation||USD$20.1 million|
TTM: trailing 12 months
There are currently 63,908 CHF Solutions shares held short by investors – that's known as CHF Solutions's "short interest". This figure is 46.3% down from 119,049 last month.
There are a few different ways that this level of interest in shorting CHF Solutions shares can be evaluated.
CHF Solutions's "short interest ratio" (SIR) is the quantity of CHF Solutions shares currently shorted divided by the average quantity of CHF Solutions shares traded daily (recently around 206154.83870968). CHF Solutions's SIR currently stands at 0.31. In other words for every 100,000 CHF Solutions shares traded daily on the market, roughly 310 shares are currently held short.
However CHF Solutions's short interest can also be evaluated against the total number of CHF Solutions shares, or, against the total number of tradable CHF Solutions shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CHF Solutions's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 CHF Solutions shares in existence, roughly 20 shares are currently held short) or 0.0234% of the tradable shares (for every 100,000 tradable CHF Solutions shares, roughly 23 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against CHF Solutions.
Find out more about how you can short CHF Solutions stock.
We're not expecting CHF Solutions to pay a dividend over the next 12 months.
CHF Solutions's shares were split on a 1:30 basis on 19 October 2020. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your CHF Solutions shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for CHF Solutions shares which in turn could have impacted CHF Solutions's share price.
Over the last 12 months, CHF Solutions's shares have ranged in value from as little as $0.28 up to $38.7. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while CHF Solutions's is 1.5617. This would suggest that CHF Solutions's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
CHF Solutions, Inc., a medical device company, focuses on developing, manufacturing, and commercializing devices used in ultrafiltration therapy. The company's commercial product is the Aquadex FlexFlow System, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct Salesforce in the United States; and through independent specialty distributors primarily in the United Kingdom, Italy, Spain, Germany, Austria, Switzerland, Southeast Asia, Brazil, India, and Greece. The company was formerly known as Sunshine Heart, Inc. and changed its name to CHF Solutions, Inc. in May 2017. CHF Solutions, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Steps to owning and managing SSNC, with 24-hour and historical pricing before you buy.
Steps to owning and managing SMBC, with 24-hour and historical pricing before you buy.
Steps to owning and managing SMED, with 24-hour and historical pricing before you buy.
Steps to owning and managing SJW, with 24-hour and historical pricing before you buy.
Steps to owning and managing SFBS, with 24-hour and historical pricing before you buy.
Steps to owning and managing LEDS, with 24-hour and historical pricing before you buy.
Steps to owning and managing SC, with 24-hour and historical pricing before you buy.
Steps to owning and managing RTW, with 24-hour and historical pricing before you buy.
Steps to owning and managing RIVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing RVSB, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.